Evelien G. E. Hurkmans, Jan B. Koenderink, Jeroen J. M. W. van den Heuvel, Yvonne M. H. Versleijen-Jonkers, Melissa H. S. Hillebrandt-Roeffen, Johanne M. Groothuismink, . . . Marieke J. H. Coenen. (2022). SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin. Frontiers Media S.A..
Chicago Style (17th ed.) CitationEvelien G. E. Hurkmans, et al. SLC7A8 Coding for LAT2 Is Associated with Early Disease Progression in Osteosarcoma and Transports Doxorubicin. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationEvelien G. E. Hurkmans, et al. SLC7A8 Coding for LAT2 Is Associated with Early Disease Progression in Osteosarcoma and Transports Doxorubicin. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.